申请人:Biots Scientific Management Pty Ltd
公开号:US08088791B2
公开(公告)日:2012-01-03
Compounds of formula (I) have antibacterial activity:
wherein R represents hydrogen or 1, 2 or 3 optional substituents; W is ═C(R1)— or ═N—; R1 is hydrogen or an optional substituent and R2 is hydrogen, methyl, or fluorine; or R1 and R2 taken together are —CH2—, —CH2CH2—, —O—, or, in either orientation, —O—CH2— or —OCH2CH2—; R3 is a radical of formula -(Alk1)m-(Z)p-(Alk2)n-Q wherein m, p and n are independently 0 or 1, provided that at least one of m, p and n is 1, Z is —O—, —S—, —S(O)—, —S(O2)—, —NH—, —N(CH3)—, —N(CH2CH3)—, —C(═O)—, —O—(C═O)—, —C(═O)—O—, or an optionally substituted divalent monocyclic carbocyclic or heterocyclic radical having 3 to 6 ring atoms; or an optionally substituted divalent bicyclic heterocyclic radical having 5 to 10 ring atoms; Alk1 and Alk2 are optionally substituted C1-C6 alkylene, C2-C6 alkenylene, or C2-C6 alkynylene radicals, which may optionally terminate with or be interrupted by —O—, —S—, —S(O)—, —S(O2)—, —NH—, —N(CH3)—, or —N(CH2CH3)—; and Q is hydrogen, halogen, nitrile, or hydroxyl or an optionally substituted monocyclic carbocyclic or heterocyclic radical having 3 to 6 ring atoms; or an optionally substituted bicyclic heterocyclic radical having 5 to 10 ring atoms.
式(I)的化合物具有抗菌活性:
其中R代表氢或1、2或3个可选取代基团;W为═C(R1)—或═N—;R1为氢或可选取代基团,R2为氢、甲基或氟;或R1和R2共同为—CH2—、—CH2CH2—、—O—或,在任一方向上,为—O—CH2—或—OCH2CH2—;R3为式-(Alk1)m-(Z)p-(Alk2)n-Q的基团,其中m、p和n独立地为0或1,但至少有一个为1,Z为—O—、—S—、—S(O)—、—S(O2)—、—NH—、—N(CH3)—、—N(CH2CH3)—、—C(═O)—、—O—(C═O)—、—C(═O)—O—或具有3至6个环原子的可选取代的单环芳环或杂环基团;或具有5至10个环原子的可选取代的双环杂环基团;Alk1和Alk2为可选取代的C1-C6烷基、C2-C6烯基或C2-C6炔基基团,可以选择以或被—O—、—S—、—S(O)—、—S(O2)—、—NH—、—N(CH3)—或—N(CH2CH3)—终止或中断;Q为氢、卤素、腈或羟基或具有3至6个环原子的可选取代的单环芳环或杂环基团;或具有5至10个环原子的可选取代的双环杂环基团。